SUBMIT AN ABSTRACT

LATE-BREAKING ABSTRACT SUBMISSION INFORMATION AND DEADLINES

Don’t miss out on a great opportunity to submit an abstract for the 49th Annual ONS Congress.

ONS is accepting abstracts in only the following categories:

• Research
• Please carefully review the definitions in the Research Abstract Subcategories section to ensure your abstract meets the Research definition before submitting.
• Non-NCPD Industry Supported

During the submission process, you will also select a subcategory that best describes your abstract. If your abstract is accepted for a poster presentation, it will be grouped with other posters in the same subcategory.

• Coordination of Care
• End of Life
• Oncology Nursing Practice
• Patient Education and Safety
• Professional Development
• Psychosocial Dimensions of Care
• Screening, Early Detection, and Genetic Risk
• Survivorship
• Symptom Management and Palliative Care
• Treatment Modalities

Note: Research abstracts have unique subcategories, listed in the Information for Research Abstracts section below.

Selection of abstracts will be based solely on a blind peer review. Abstracts may be selected for oral presentation sessions or poster presentations and will be published in the March issue of the online Oncology Nursing Forum .

Note: Abstracts cannot be edited after the submission deadline and will be published as received. This includes changes in authors, presenters, or results. Pay close attention to spelling, grammar, names, and credentials.

IMPORTANT DEADLINES

1. GUIDELINES

   1. All abstracts must be submitted by the primary author.
      
   2. For abstracts with more than one author, the primary author will be the contact person and presenter. All communication will be sent to the primary author only. Changes to the contact person cannot be made after submission.
      Note: The abstract submission system allows a maximum of 6 authors. No additional authors can be added past the 6 authors.
   3. The title and authors must not be included in the body of the abstract. Any references that could identify the author/investigators by name or organization within the body of the text should be removed to allow for a blind peer review.
   4. The components of the abstract should be divided into the following sections to help authors ensure that all required information based upon the scoring criteria is included (See Abstract Scoring Criteria below.). Authors should write the abstract in a word processing system (e.g. Word) using this template. Save your document in your own files for future reference, then copy and paste the appropriate sections with the section headers into the abstract system. Please double check to ensure special characters are copied correctly. No edits can be made after submission and prior to publishing.
   1. Abstract Scoring Criteria Sections:
   1. Significance
   2. Purpose
   3. Interventions
   4. Evaluation
   5. Discussion
   2. In addition to the sections listed, reviewers will also score your submission on the Presentation and Innovation of the topic.
   5. The final abstract (body of abstract) must be no more than 385 words, including the Section Headers. Abstracts that contain more than the specified number of words will not be reviewed. We suggest checking the word count of your abstract in a word processing program prior to copying and pasting the abstract into the online submission form.
   6. Attaching a figure or table: You may include one image file with your abstract. The image file may include more than one figure, table or image. All figures or images in the file must have titles. Words in the image file are not included in the total character count. Images will not be included in publication.
      
   7. Submitting your abstract:
   1. The abstract cannot be submitted unless all required fields are completed.
   2. The abstract title should clearly indicate the nature of the subject. Acronyms should not be used in the title and should be written out on first mention.  A quantifiable objective must be submitted and the body of the abstract should be in paragraph form, using complete sentences, and avoiding special characters. Abstracts should include, no more than six authors' names (first and last names), credentials, and institution or place of employment’s name, city and state. Abstracts should have all funding sources written out completely if applicable.
      
   3. A quantifiable objective must be submitted and the body of the abstract should be in paragraph form, using complete sentences, and avoiding special characters. All funding sources should be written out completely, if applicable.
   8. The abstract must be approved for submission and presentation by the authors’ employing institution(s).
   9. No previously published or presented (aka encore) abstracts will be accepted. Secondary analyses/endpoints are acceptable. Previous ONS Congress abstracts are ineligible for resubmission as they have been previously published. All submissions will be reviewed for originality via iThenticate. Abstracts identified as previously published will be removed from consideration for this ONS Congress.
   10. Research in progress will be considered for e-Poster presentation only. Consider submitting abstract in late breaking call for abstracts (December 11, 2023 - January 11, 2024) if data isn't available for first abstract call.
   11. Data published in abstracts accepted are embargoed and may not be presented or published elsewhere until the conclusion of ONS Congress. Coverage and/or distribution of an abstract, poster, or any of its supplemental material to or by the news media, any commercial entity, or individuals, including the authors of said abstract, is strictly prohibited until the embargo is lifted.
   12. Authors retain copyright ownership of all original material submitted.
   13. Primary authors may decline acceptance or withdraw presentation of an abstract selection by emailing conferences@ons.org.

2. AUTHORSHIP

   Primary authors must be either a registered nurse, a licensed healthcare professional from another discipline (physician, pharmacist, physical therapist, etc.), or a doctorally-prepared individual.

   For abstracts with more than one author, the primary author is the sole contact person and presenter. The primary author/contact person may not be changed and is the only person who can upload information if the abstract is accepted for poster or oral presentation.

   Abstracts submitted must be of the author's own completed work, work in progress, or work previously presented at the local or regional level. Abstracts may not be submitted that contain information that has been previously published or presented to national or international oncology nursing audiences.

   All primary abstract authors must complete the Presenter Agreement to meet the ONS NCPD Provider Unit requirements. This form is available in the submission system and includes the following.

   • Full Disclosure/Conflict of Interest

   Financial relationships are relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g. stocks, stock options, or other ownership interest, excluding diversified mutual fund(s), or other financial benefit. Financial relationships can also include “contracted research” where the institution gets the grant and manages the funds and the individual is the principal or named investigator on the grant. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. A relevant financial relationship is any relationship in any amount occurring in the past 24 months (as of the date that the form is completed) that creates a conflict of interest.  There is a lot of press recently on commercial influence over continuing education in medicine and nursing.  It’s important to identify potential conflicts to the planning team as well as to the audience. Without this information, there is not full disclosure. Without full disclosure there is the implication there is information to hide and bias is inherent in hiding information.

   • Warranty & Indemnity

   Warrant that you are the author of your presentation, that the presentation is original, except for such excerpts from copyrighted material included with the permission of the copyright owner and that you indemnify or release ONS against any and all liabilities, claims, or damages that would arise. You agree that the presentation is your own work, excerpts of copyright of materials are used with the expressed permission of the owner, presentation has not been developed as part of another presentation, and that it may be included within the ONS marketing materials.

3. THE REVIEW PROCESS

   1. Upon receipt, the abstract will be reviewed for compliance with the abstract instructions and assigned a number to ensure anonymity.
   2. Three ONS member volunteers with the appropriate experience in leadership, management, education, clinical/evidence-based practice, advanced practice or research will blind review each abstract.
   3. Reviewers will use one of the following sets of scoring criteria, depending on the abstract’s content area. Each item is scored on a scale of 1-5 grading scale (1=not at all; 5=high).
   4. The conference planning team will rank order abstracts for presentation at the conference.

BEGIN A SUBMISSION